CN111214585A - Ganoderma lucidum whole deer life prolonging composition, preparation method thereof and ganoderma lucidum whole deer life prolonging paste - Google Patents
Ganoderma lucidum whole deer life prolonging composition, preparation method thereof and ganoderma lucidum whole deer life prolonging paste Download PDFInfo
- Publication number
- CN111214585A CN111214585A CN202010168047.4A CN202010168047A CN111214585A CN 111214585 A CN111214585 A CN 111214585A CN 202010168047 A CN202010168047 A CN 202010168047A CN 111214585 A CN111214585 A CN 111214585A
- Authority
- CN
- China
- Prior art keywords
- parts
- deer
- ganoderma lucidum
- ganoderma
- paste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000282994 Cervidae Species 0.000 title claims abstract description 68
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 240000008397 Ganoderma lucidum Species 0.000 title claims abstract description 27
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims description 16
- 241000222336 Ganoderma Species 0.000 claims abstract description 24
- 241001492697 Centropogon cornutus Species 0.000 claims abstract description 21
- 210000003899 penis Anatomy 0.000 claims abstract description 21
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 19
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 19
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 19
- 239000011669 selenium Substances 0.000 claims abstract description 19
- 239000009636 Huang Qi Substances 0.000 claims abstract description 12
- 210000001550 testis Anatomy 0.000 claims abstract description 10
- 239000000706 filtrate Substances 0.000 claims description 28
- 239000006072 paste Substances 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 17
- 244000223072 Narcissus jonquilla Species 0.000 claims description 14
- 235000013862 Narcissus jonquilla Nutrition 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 14
- 239000012530 fluid Substances 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- 241000005787 Cistanche Species 0.000 claims description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 9
- 240000000171 Crataegus monogyna Species 0.000 claims description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 9
- 244000185386 Thladiantha grosvenorii Species 0.000 claims description 9
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims description 9
- 235000006533 astragalus Nutrition 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241001061264 Astragalus Species 0.000 claims description 7
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 7
- 244000182216 Mimusops elengi Species 0.000 claims description 7
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 7
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 210000004233 talus Anatomy 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 6
- 241001116389 Aloe Species 0.000 claims description 4
- 235000011399 aloe vera Nutrition 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 239000003973 paint Substances 0.000 claims 1
- 238000005554 pickling Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 5
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 230000002929 anti-fatigue Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000032683 aging Effects 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000003832 immune regulation Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 208000017971 listlessness Diseases 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- -1 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- ZAVXXBAIPSQJGS-UHFFFAOYSA-B tetracalcium;tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O.[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O.[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ZAVXXBAIPSQJGS-UHFFFAOYSA-B 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a ganoderma lucidum whole deer life-prolonging composition which comprises the following components: ganoderma, young deer meat, deer tail, penis et testis Cervi, ligamentum Cervi, CHANGSHOUCAO, fructus crataegi, fructus Lycii, radix astragali, fructus Siraitiae Grosvenorii, Cistanchis herba, selenium-rich yeast, and dried arillus longan. The lucid ganoderma-deer meat-deer tail-deer penis-deer sinew health-care product takes lucid ganoderma, deer meat, deer tail, deer penis and deer sinew as monarch drugs and is supplemented with other traditional Chinese medicines, all the components are matched with each other to enhance the resistance of a human body, the sleep state can be improved after long-term use, people can sleep well more easily, the anti-fatigue feeling can be effectively enhanced, and the lucid ganoderma-deer tail health-care product has a very excellent effect on recovery of the fatigue feeling.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a ganoderma lucidum whole deer life-prolonging composition and a preparation method thereof.
Technical Field
Modern immunology recognizes that immunity is the body's own defense mechanism, and is the body's ability to recognize and destroy any foreign body (virus, bacteria, etc.) that has been invaded from the outside, to treat aged, damaged, dead, denatured, self-cells, and to recognize and treat mutant and virally infected cells in the body. The most direct manifestations of hypoimmunity are the excessive consumption of body energy, physical weakness, fatigue, drowsiness, susceptibility to common cold, listlessness, decreased appetite, chest distress, short breath, soreness of the waist and back, insomnia, and premature senility. In the past, the traditional Chinese medicine composition causes poor development of body and intelligence, and is also easy to induce serious diseases, such as cardiovascular and cerebrovascular diseases, diabetes, hypertension, hyperlipidemia, fatty liver, obesity and the like, and even cancers. Medically, the key point of getting rid of stubborn chronic diseases is to mobilize the immunity of the human body and fully utilize the immune regulation, so that the human body can establish a natural disease-resistant barrier. Therefore, the immune dysfunction of the human body cannot be seen.
With the change of living environment, the modern society accelerates the pace of life, excessive mental and physical labor, mental stress and the like, people feel that the body resistance is reduced, and low immunity and sub-health are health problems concerned by the society, so that health care products for improving the immunity of the human body and enhancing the mechanism of the human body are needed by the society, but the common effect of the products for improving the immunity in the market is poor, and the requirements of most people cannot be met.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a ganoderma lucidum whole deer life-prolonging composition and a preparation method thereof.
The specific scheme is as follows:
a Ganoderma lucidum whole deer life prolonging composition comprises the following components: ganoderma, young deer meat, deer tail, penis et testis Cervi, ligamentum Cervi, CHANGSHOUCAO, fructus crataegi, fructus Lycii, radix astragali, fructus Siraitiae Grosvenorii, Cistanchis herba, selenium-rich yeast, and dried arillus longan.
The invention relates to a specific implementation mode which comprises the following components in parts by weight: 2-8 parts of lucid ganoderma, 1-3 parts of young deer meat, 1-3 parts of deer tail, 1-3 parts of deer penis, 1-3 parts of deer sinew, 2-6 parts of jonquil, 10-20 parts of hawthorn, 15-30 parts of medlar, 1-4 parts of astragalus, 6-9 parts of momordica grosvenori, 5-12 parts of cistanche, 1-3 parts of selenium-enriched yeast, 30-40 parts of dried longan and 1-80 parts of auxiliary materials.
The invention relates to a specific implementation mode which comprises the following components in parts by weight: 6-8 parts of lucid ganoderma, 1-2 parts of young deer meat, 1-2 parts of deer tail, 1-2 parts of deer penis, 1-2 parts of deer sinew, 2-3 parts of jonquil, 10-15 parts of hawthorn, 15-25 parts of medlar, 2-4 parts of astragalus, 6-7 parts of momordica grosvenori, 8-12 parts of cistanche, 1-3 parts of selenium-enriched yeast, 35-40 parts of dried longan and 5-50 parts of auxiliary materials.
The invention also comprises 15-20 parts of edible aloe.
In one embodiment of the invention, the excipient is selected from the group consisting of binders, fillers, diluents, lubricants, flavoring agents and humectants.
In a specific embodiment of the invention, the preparation of the composition comprises powder, granules, pills, powder, paste, pellets and suspension.
In a specific embodiment of the invention, the paste comprises a blend paste, a pounding paste, a decoction paste and a curing paste.
The composition of the present invention, its oral preparation, may contain conventional excipients such as binders, fillers, diluents, lubricants, flavoring agents and wetting agents, and the tablets may be coated if necessary.
Suitable fillers include cellulose, mannitol, lactose and other similar fillers. Suitable lubricants include, for example, magnesium stearate. Suitable pharmaceutically acceptable wetting agents include sodium lauryl sulphate. The solid oral compositions can be prepared by conventional methods of mixing, filling, tabletting and the like. Repeated mixing can distribute the active throughout those compositions that use large amounts of filler.
Oral liquid preparations may be in the form of, for example, aqueous or oily suspensions, solutions, emulsions or syrups, or may be presented as a dry product for constitution with water or other suitable vehicle before use. Such liquid preparations may contain conventional additives such as suspending agents, for example sorbitol, syrup, methyl cellulose, gelatin, hydroxyethyl cellulose, carboxymethyl cellulose, aluminium stearate gel or hydrogenated edible fats, emulsifying agents, for example lecithin, sorbitan monooleate or acacia; non-aqueous carriers (which may include edible oils), for example almond oil, fractionated coconut oil, oily esters such as esters of glycerol, propylene glycol or ethyl alcohol; preservatives, for example p-hydroxybenzyl or propyl p-hydroxybenzoate or sorbic acid, and, if desired, conventional flavouring or colouring agents.
the composition of the invention can be selectively added with a suitable pharmaceutically acceptable carrier when being prepared into a medicament, wherein the pharmaceutically acceptable carrier is selected from mannitol, sorbitol, sodium metabisulfite, sodium bisulfite, sodium thiosulfate, cysteine hydrochloride, thioglycolic acid, methionine, vitamin C, EDTA disodium, EDTA calcium sodium, carbonate, acetate, phosphate or aqueous solution thereof of monovalent alkali metals, hydrochloric acid, acetic acid, sulfuric acid, phosphoric acid, amino acid, sodium chloride, potassium chloride, sodium lactate, xylitol, maltose, glucose, fructose, dextran, glycine, starch, sucrose, lactose, mannitol, silicon derivatives, cellulose and derivatives thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, Tween 80, agar, calcium carbonate, calcium bicarbonate, surfactant, polyethylene glycol, cyclodextrin, β -cyclodextrin, phospholipid materials, kaolin, talcum powder, calcium stearate, magnesium stearate and the like.
The above-mentioned adjuvants such as carrier, excipient and the like are not limited to the use in a specific dosage form.
The invention also provides a preparation method of the ganoderma lucidum whole deer life prolonging composition, which comprises the following steps:
1) preparing raw materials according to the components;
2) crushing Ganoderma, young deer meat, deer tail, penis et testis Cervi, ligamentum Cervi, jonquil, fructus crataegi, fructus Lycii, radix astragali, fructus Siraitiae Grosvenorii, Cistanchis herba, selenium-enriched yeast, and dried longan into coarse pieces, heating and decocting for 3-6 times, adding 8-10 times of water into each decoction, keeping the temperature for 35-60min after each decoction is boiled, filtering after each decoction to obtain filtrate, mixing the filtrates after the decoction is finished, standing for 3-6h, and filtering to obtain filtrate for later use; drying the filter residue and grinding into filter residue powder for later use;
3) concentrating the filtrate obtained in 2) under reduced pressure, and concentrating at 70-80 deg.C to obtain fluid extract with relative density of 1.1-1.2;
4) mixing the fluid extract obtained in step 3) with the rest raw materials and the residue powder, and further processing according to the requirement to obtain the product with corresponding dosage form.
The invention provides a product containing a ganoderma lucidum whole deer life prolonging composition, and particularly relates to ganoderma lucidum whole deer life prolonging paste which can be prepared by adopting the method.
Ganoderma lucidum is sweet and bitter in taste and neutral in nature, and enters heart, lung, liver and spleen channels; has effects in nourishing heart, tranquilizing mind, nourishing lung, invigorating qi, regulating qi, dispelling blood stasis, nourishing liver, and invigorating spleen. It can be used for treating asthenia, listlessness, palpitation, insomnia, dizziness, cough, asthma, anorexia, reaction retardation, and short breath. The contained germanium can increase the oxygen absorption capacity of the blood of a human body by 1.5 times, thereby promoting metabolism, having the function of delaying aging, also having the function of enhancing the repair function of the skin, and being used for the symptoms of facial chlorosis caused by various chronic diseases, facial luster caused by deficiency of qi and blood and the like; the organic germanium contained in Ganoderma can induce human body to generate and activate NK cell and macrophage activity, and participate in immune regulation. The polysaccharide in the ganoderma lucidum has the functions of regulating the immunity of organisms in a two-way manner, resisting tumors and protecting liver; the alkaloids in Ganoderma have antiinflammatory and analgesic effects; the Ganoderma spore powder has hemostatic, toxic materials clearing away, and antioxidant effects.
The Changshoucao herb can absorb rich saccharide, mineral matter and vitamins, promote metabolism and eliminate toxin accumulated in human body, and has high health effect. The cellulose in the longevity grass can clear cholesterol in a human body, prevent fat accumulation, and accelerate the decomposition and metabolism of fat in the human body, thereby playing an important role in reducing fat and losing weight.
The flavonoids, vitamin C, carotene, etc. contained in fructus crataegi can block and reduce free radical generation, enhance immunity, and prevent aging and cancer.
Fructus Lycii has effects of invigorating kidney, replenishing vital essence, nourishing liver, improving eyesight, replenishing blood, tranquilizing mind, promoting fluid production, quenching thirst, moistening lung, and relieving cough. It is indicated for liver and kidney yin deficiency, soreness and weakness of waist and knees, dizziness, blurred vision, hyperdacryosis, cough due to asthenia, diabetes, and spermatorrhea.
Radix astragali has effects of reducing blood viscosity, reducing thrombosis, lowering blood pressure, protecting heart, regulating blood sugar, resisting free radical injury, resisting aging, resisting anoxia, resisting tumor, and enhancing immunity, and can be used for treating heart disease, hypertension, diabetes, etc. Radix astragali can also dilate blood vessel, improve skin blood circulation and nutrition status.
Cistanche deserticola is a food used as both medicine and food, can play a role in enhancing physical strength, and can also well enhance physical endurance and resist fatigue. Can also improve the aging symptoms of organisms, is beneficial to restoring energy, physical strength and vitality, and has very good effect of delaying aging.
Compared with the prior art, the invention has the beneficial effects that:
the lucid ganoderma-deer meat-deer tail-deer penis-deer sinew health-care product takes lucid ganoderma, deer meat, deer tail, deer penis and deer sinew as monarch drugs and is supplemented with other traditional Chinese medicines, all the components are matched with each other to enhance the resistance of a human body, the sleep state can be improved after long-term use, people can sleep well more easily, the anti-fatigue feeling can be effectively enhanced, and the lucid ganoderma-deer tail health-care product has a very excellent effect on recovery of the fatigue feeling.
Detailed Description
The technical solutions of the present invention will be described clearly and completely below, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
Example 1
A preparation method of a ganoderma lucidum whole deer life prolonging composition comprises the following steps:
1) preparing raw materials according to the components; according to the weight parts, 2 parts of lucid ganoderma, 1 part of young deer meat, 1 part of deer tail, 1 part of deer penis, 1 part of deer sinew, 2 parts of longevous herb, 10 parts of hawthorn, 15 parts of medlar, 1 part of astragalus, 6 parts of momordica grosvenori, 5 parts of cistanche, 1 part of selenium-enriched yeast, 30 parts of dried longan and 35 parts of auxiliary materials;
2) crushing Ganoderma, young deer meat, deer tail, penis et testis Cervi, ligamentum Cervi, herba jonquil, fructus crataegi, fructus Lycii, radix astragali, fructus Siraitiae Grosvenorii, Cistanchis herba, selenium-enriched yeast, and dried longan into coarse pieces, heating and decocting for 3 times, adding 8 times of water for each time, decocting for boiling, keeping the temperature for 35min, filtering after each time, collecting filtrate, mixing filtrates after decocting, standing for 3h, and filtering to obtain filtrate for use; drying the filter residue and grinding into filter residue powder for later use;
3) concentrating the filtrate obtained in 2) under reduced pressure, and concentrating at 70 deg.C to obtain fluid extract with relative density of 1.1-1.2;
4) mixing the fluid extract obtained in step 3) with the rest raw materials and the residue powder to prepare paste.
Example 2
A preparation method of a ganoderma lucidum whole deer life prolonging composition comprises the following steps:
1) preparing raw materials according to the components; the feed comprises, by weight, 6 parts of lucid ganoderma, 1 part of young deer meat, 2 parts of deer tail, 1 part of deer penis, 2 parts of deer sinew, 2 parts of jonquil, 10 parts of hawthorn, 15 parts of wolfberry fruit, 2 parts of astragalus membranaceus, 6 parts of momordica grosvenori, 8 parts of cistanche, 1 part of selenium-enriched yeast, 35 parts of dried longan and 35 parts of auxiliary materials;
2) crushing Ganoderma, young deer meat, deer tail, penis et testis Cervi, ligamentum Cervi, herba jonquil, fructus crataegi, fructus Lycii, radix astragali, fructus Siraitiae Grosvenorii, Cistanchis herba, selenium-enriched yeast, and dried longan into coarse pieces, heating and decocting for 4 times, adding 8 times of water for each time, decocting for boiling, keeping the temperature for 40min, filtering after each time, collecting filtrate, mixing filtrates after decocting, standing for 4h, and filtering to obtain filtrate for use; drying the filter residue and grinding into filter residue powder for later use;
3) concentrating the filtrate obtained in 2) under reduced pressure, and concentrating at 70 deg.C to obtain fluid extract with relative density of 1.1-1.2;
4) mixing the clear paste obtained in the step 3) with the rest raw materials and the filter residue powder, and preparing a product of paste according to the requirement.
Example 3
A preparation method of a ganoderma lucidum whole deer life prolonging composition comprises the following steps:
1) preparing raw materials according to the components; according to the weight parts, 8 parts of lucid ganoderma, 2 parts of young deer meat, 2 parts of deer tail, 2 parts of deer penis, 9 parts of deer sinew, 3 parts of jonquil, 15 parts of hawthorn, 25 parts of wolfberry fruit, 4 parts of astragalus root, 7 parts of momordica grosvenori, 8-12 parts of cistanche, 3 parts of selenium-enriched yeast, 40 parts of dried longan, 50 parts of auxiliary material and 20 parts of edible aloe;
2) crushing Ganoderma, young deer meat, deer tail, penis et testis Cervi, ligamentum Cervi, herba jonquil, fructus crataegi, fructus Lycii, radix astragali, fructus Siraitiae Grosvenorii, Cistanchis herba, selenium-enriched yeast, and dried longan into coarse pieces, heating and decocting for 5 times, adding 8 times of water for each time, decocting for boiling, keeping the temperature for 40min, filtering after each time, collecting filtrate, mixing filtrates after decocting, standing for 4.5h, and filtering to obtain filtrate for use; drying the filter residue and grinding into filter residue powder for later use;
3) concentrating the filtrate obtained in 2) under reduced pressure, and concentrating at 70-80 deg.C to obtain fluid extract with relative density of 1.1-1.2;
4) mixing the clear paste obtained in the step 3) with the rest raw materials and the filter residue powder, and preparing a product of paste according to the requirement.
Example 4
A preparation method of a ganoderma lucidum whole deer life prolonging composition comprises the following steps:
1) preparing raw materials according to the components; according to the weight parts, 8 parts of lucid ganoderma, 3 parts of young deer meat, 2 parts of deer tail, 1 part of deer penis, 3 parts of deer sinew, 5 parts of jonquil, 17 parts of hawthorn, 25 parts of medlar, 3 parts of astragalus, 7 parts of momordica grosvenori, 10 parts of cistanche, 2 parts of selenium-enriched yeast, 35 parts of dried longan, 60 parts of auxiliary materials and 20 parts of edible aloe;
2) crushing Ganoderma, young deer meat, deer tail, penis et testis Cervi, ligamentum Cervi, herba jonquil, fructus crataegi, fructus Lycii, radix astragali, fructus Siraitiae Grosvenorii, Cistanchis herba, selenium-enriched yeast, and dried longan into coarse pieces, heating and decocting for 5 times, adding 9 times of water for each time, decocting for boiling, keeping the temperature for 50min, filtering after each time, collecting filtrate, mixing filtrates after decocting, standing for 5h, and filtering to obtain filtrate for use; drying the filter residue and grinding into filter residue powder for later use;
3) concentrating the filtrate obtained in 2) under reduced pressure, and concentrating at 80 deg.C to obtain fluid extract with relative density of 1.1-1.2;
4) mixing the clear paste obtained in the step 3) with the rest raw materials and the filter residue powder, and preparing a product of paste according to the requirement.
Example 5
A preparation method of a ganoderma lucidum whole deer life prolonging composition comprises the following steps:
1) preparing raw materials according to the components; according to the weight parts, 8 parts of lucid ganoderma, 3 parts of young deer meat, 3 parts of deer tail, 3 parts of deer penis, 3 parts of deer sinew, 6 parts of longevous herb, 20 parts of hawthorn, 30 parts of medlar, 4 parts of astragalus, 9 parts of momordica grosvenori, 12 parts of cistanche, 3 parts of selenium-enriched yeast, 40 parts of dried longan and 80 parts of auxiliary materials;
2) crushing Ganoderma, young deer meat, deer tail, penis et testis Cervi, ligamentum Cervi, jonquil, fructus crataegi, fructus Lycii, radix astragali, fructus Siraitiae Grosvenorii, Cistanchis herba, selenium-enriched yeast, and dried longan into coarse pieces, heating and decocting for 6 times, adding 10 times of water for each time, decocting for boiling, keeping the temperature for 60min, filtering after each time, collecting filtrate, mixing filtrates after decocting, standing for 6h, and filtering to obtain filtrate for use; drying the filter residue and grinding into filter residue powder for later use;
3) concentrating the filtrate obtained in 2) under reduced pressure, and concentrating at 80 deg.C to obtain fluid extract with relative density of 1.1-1.2;
4) mixing the fluid extract obtained in step 3) with the rest raw materials and the residue powder, and preparing into pills according to the requirement.
The foregoing is illustrative of the preferred embodiments of this invention, and it is to be understood that the invention is not limited to the precise form disclosed herein and that various other combinations, modifications, and environments may be resorted to, falling within the scope of the concept as disclosed herein, either as described above or as apparent to those skilled in the relevant art. And that modifications and variations may be effected by those skilled in the art without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (9)
1. A ganoderma lucidum whole deer longevity composition is characterized by comprising the following components: ganoderma, young deer meat, deer tail, penis et testis Cervi, ligamentum Cervi, CHANGSHOUCAO, fructus crataegi, fructus Lycii, radix astragali, fructus Siraitiae Grosvenorii, Cistanchis herba, selenium-rich yeast, and dried arillus longan.
2. The ganoderma lucidum whole deer longevity composition according to claim 1, which is characterized by comprising the following components in parts by weight: 2-8 parts of lucid ganoderma, 1-3 parts of young deer meat, 1-3 parts of deer tail, 1-3 parts of deer penis, 1-3 parts of deer sinew, 2-6 parts of jonquil, 10-20 parts of hawthorn, 15-30 parts of medlar, 1-4 parts of astragalus, 6-9 parts of momordica grosvenori, 5-12 parts of cistanche, 1-3 parts of selenium-enriched yeast, 30-40 parts of dried longan and 1-80 parts of auxiliary materials.
3. The ganoderma lucidum whole deer longevity composition of claim 1, wherein: the paint comprises the following components in parts by weight: 6-8 parts of lucid ganoderma, 1-2 parts of young deer meat, 1-2 parts of deer tail, 1-2 parts of deer penis, 1-2 parts of deer sinew, 2-3 parts of jonquil, 10-15 parts of hawthorn, 15-25 parts of medlar, 2-4 parts of astragalus, 6-7 parts of momordica grosvenori, 8-12 parts of cistanche, 1-3 parts of selenium-enriched yeast, 35-40 parts of dried longan and 5-50 parts of auxiliary materials.
4. The ganoderma lucidum whole deer longevity composition according to any one of claims 2 or 3, wherein: also comprises 15-20 parts of edible aloe.
5. The ganoderma lucidum whole deer longevity composition according to any one of claims 2 or 3, wherein: the adjuvants are selected from binders, fillers, diluents, lubricants, flavoring agents and humectants.
6. The ganoderma lucidum whole deer longevity composition according to any one of claims 1-5, wherein: the preparation of the composition comprises powder, granules, pills, powder, paste, pellets and suspension.
7. The ganoderma lucidum whole deer longevity composition of claim 6, wherein: the paste comprises blending paste, pounding paste, decocting paste, and pickling paste.
8. A preparation method of a ganoderma lucidum whole deer life prolonging composition is characterized by comprising the following steps:
1) preparing raw materials according to the components;
2) crushing Ganoderma, young deer meat, deer tail, penis et testis Cervi, ligamentum Cervi, jonquil, fructus crataegi, fructus Lycii, radix astragali, fructus Siraitiae Grosvenorii, Cistanchis herba, selenium-enriched yeast, and dried longan into coarse pieces, heating and decocting for 3-6 times, adding 8-10 times of water into each decoction, keeping the temperature for 35-60min after each decoction is boiled, filtering after each decoction to obtain filtrate, mixing the filtrates after the decoction is finished, standing for 3-6h, and filtering to obtain filtrate for later use; drying the filter residue and grinding the filter residue into powder for later use;
3) concentrating the filtrate obtained in 2) under reduced pressure, and concentrating at 70-80 deg.C to obtain fluid extract with relative density of 1.1-1.2;
4) mixing the fluid extract obtained in step 3) with the rest raw materials, and further processing according to the requirement to obtain the product with corresponding dosage form.
9. A ganoderma lucidum whole deer life prolonging paste is characterized in that: prepared by the method of claim 8.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010168047.4A CN111214585A (en) | 2020-03-11 | 2020-03-11 | Ganoderma lucidum whole deer life prolonging composition, preparation method thereof and ganoderma lucidum whole deer life prolonging paste |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010168047.4A CN111214585A (en) | 2020-03-11 | 2020-03-11 | Ganoderma lucidum whole deer life prolonging composition, preparation method thereof and ganoderma lucidum whole deer life prolonging paste |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111214585A true CN111214585A (en) | 2020-06-02 |
Family
ID=70812425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010168047.4A Pending CN111214585A (en) | 2020-03-11 | 2020-03-11 | Ganoderma lucidum whole deer life prolonging composition, preparation method thereof and ganoderma lucidum whole deer life prolonging paste |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111214585A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1197841A (en) * | 1998-05-26 | 1998-11-04 | 倪颖 | Lubao wine and its preparation |
CN1824758A (en) * | 2005-12-22 | 2006-08-30 | 仪征市龙山鹿业科技有限公司 | Deer wine and its production method |
CN103637198A (en) * | 2013-12-05 | 2014-03-19 | 尚诚德 | Blood glucose-reducing life-prolonging paste |
CN109123032A (en) * | 2018-09-12 | 2019-01-04 | 江西天元药业有限公司 | Composition and preparation process with warm kidney yang-tonifying warm kidney benefiting yin function of promoting longevity |
CN110452799A (en) * | 2019-08-28 | 2019-11-15 | 熊飞 | A kind of deer-blood wine |
-
2020
- 2020-03-11 CN CN202010168047.4A patent/CN111214585A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1197841A (en) * | 1998-05-26 | 1998-11-04 | 倪颖 | Lubao wine and its preparation |
CN1824758A (en) * | 2005-12-22 | 2006-08-30 | 仪征市龙山鹿业科技有限公司 | Deer wine and its production method |
CN103637198A (en) * | 2013-12-05 | 2014-03-19 | 尚诚德 | Blood glucose-reducing life-prolonging paste |
CN109123032A (en) * | 2018-09-12 | 2019-01-04 | 江西天元药业有限公司 | Composition and preparation process with warm kidney yang-tonifying warm kidney benefiting yin function of promoting longevity |
CN110452799A (en) * | 2019-08-28 | 2019-11-15 | 熊飞 | A kind of deer-blood wine |
Non-Patent Citations (4)
Title |
---|
南朝君: "《食疗、营养与烹调》", 31 January 2014, 中国医药科技出版 * |
张朔生: "富硒虫草胶囊的毒理学实验研究", 《世界中西医结合杂志》 * |
李敏: "《千金方养生智慧》", 31 January 2018, 中医古籍出版社 * |
王艳等: "延寿口服液抗衰老作用研究", 《中国药师》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101940740B (en) | Chinese medicinal preparation for treating anemia | |
CN108434256A (en) | A kind of removing toxic substances row's fat that nourishes the liver to improve visual acuity restores the Chinese medicine preparation of liver metabolism function | |
CN104225361A (en) | Health wine with radix salviae miltiorrhizae and pseudo-ginseng and preparation method of health wine | |
CN102038138A (en) | Corn flake capable of invigorating kidney and improving eyesight | |
CN102861235B (en) | Health-maintaining preparation made of pure traditional Chinese medicines | |
CN106962921A (en) | A kind of health diet addition powder and preparation method thereof | |
CN106421432A (en) | Traditional Chinese medicine for treating aged body deficiency syndrome and delaying senescence | |
CN103830558B (en) | Anti-aging composition and preparation method thereof | |
CN102357151B (en) | Chinese medicinal composition for delaying senility and preparation process thereof | |
CN111214585A (en) | Ganoderma lucidum whole deer life prolonging composition, preparation method thereof and ganoderma lucidum whole deer life prolonging paste | |
WO2022061978A1 (en) | Compound composition with anti-oxidation and anti-aging effects, preparation method therefor and application thereof | |
CN107320631A (en) | A kind of anti-fatigue Chinese medicinal composition and preparation method thereof | |
CN102973687B (en) | Oral liquid for regulating female hormonal balance | |
CN111588029A (en) | Polygonatum sibiricum paste composition | |
CN105769956B (en) | A kind of water in which rice has been washed honey Radix Notoginseng powder processed and its preparation and preparation method | |
CN1267141C (en) | Method for preparing compound medicinal capsule and powder for nourishing yin | |
KR20050043388A (en) | Oriental health food and preparation method thereof | |
CN103933473B (en) | A kind of granule of benefiting qi and nourishing blood spot-eliminating beauty treatment and preparation method thereof | |
CN109601826A (en) | A kind of health-care flour containing ganoderma lucidum and lucidum spore powder | |
CN108853340A (en) | A kind of Chinese medicine of nourishing the liver and kidney and preparation method thereof | |
CN108782869A (en) | Stem of noble dendrobium health preserving tea | |
CN113940977B (en) | Heat-clearing and wind-extinguishing granule and preparation method thereof | |
CN107485698A (en) | A kind of Chinese medicine composition and preparation method thereof with blood nourishing acupuncture-stimulating, maintaining beauty and keeping young | |
CN106265964A (en) | A kind of health preserving tonic and preparation method thereof | |
CN106581426A (en) | Medicinal liquor for improving Qi-deficiency constitution type to reach balanced constitution type and formula thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200602 |
|
RJ01 | Rejection of invention patent application after publication |